GA
EXAS

Goldstein Advisors’s Exact Sciences EXAS Stock Holding History

Goldstein Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,200
Closed -$934K – 231
2025
Q4 		$934K Sell
9,200
-1,927
-17% -$155K 0.11% 71
2025
Q3 		$609K Buy
11,127
+1,171
+12% +$58.5K 0.07% 94
2025
Q2 		$529K Sell
9,956
-2,298
-19% -$117K 0.07% 91
2025
Q1 		$530K Buy
12,254
+6,523
+114% +$330K 0.08% 91
2024
Q4 		$322K Sell
5,731
-726
-11% -$45.2K 0.05% 129
2024
Q3 		$440K Buy
6,457
+21
+0.3% +$1.19K 0.07% 95
2024
Q2 		$272K Buy
6,436
+676
+12% +$37.2K 0.05% 127
2024
Q1 		$398K Sell
5,760
-56
-1% -$3.54K 0.07% 95
2023
Q4 		$430K Buy
5,816
+10
+0.2% +$655 0.07% 113
2023
Q3 		$396K Sell
5,806
-125
-2% -$10.6K 0.08% 83
2023
Q2 		$557K Buy
5,931
+235
+4% +$18.3K 0.12% 69
2023
Q1 		$386K Buy
5,696
+286
+5% +$18.4K 0.08% 90
2022
Q4 		$268K Buy
+5,410
New +$221K 0.06% 108

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Goldstein Advisors's EXAS Position: Q1 2026 in Review

Goldstein Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,200 shares — an estimated $934K sold.

Goldstein Advisors first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $934K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Goldstein Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Goldstein Advisors sold 9,200 Exact Sciences shares in Q1 2026, an estimated $934K.
  • Goldstein Advisors first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Goldstein Advisors's Exact Sciences position peaked at $934K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Goldstein Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.